Paper36070489
Analysis of Orthogonal Efflux and Permeation Properties of Compounds Leads to the Discovery of New Efflux Pump Inhibitors.
Moniruzzaman M and 5 others. ACS Infect Dis, 2022. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Analysis of Orthogonal Efflux and Permeation Properties of Compounds Leads to the Discovery of New Efflux Pump Inhibitors. Papers, record 36070489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36070489
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Analysis of Orthogonal Efflux and Permeation Properties of Compounds Leads to the Discovery of New Efflux Pump Inhibitors.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Escherichia coli | Major topic |
| Membrane Transport Proteins | Major topic |
| Amines | |
| Anti-Bacterial Agents | |
| Porins |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 AI052293 | NIAID NIH HHS | United States | R01AI052293 | PubMed and NIH |
Source NIH RePORTER
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32039579 | Drug Permeation against Efflux by Two Transporters. | ACS Infect Dis | 2020 | https://conductscience.org/library/papers/32039579 | PubMed |
| 2 | 19805313 | Kinetic control of TolC recruitment by multidrug efflux complexes. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19805313 | PubMed |
| 3 | 31792365 | Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/31792365 | PubMed |
| 4 | 19399780 | AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. | J Comput Chem | 2009 | https://conductscience.org/library/papers/19399780 | PubMed |
| 5 | 31588569 | AcrB: a mean, keen, drug efflux machine. | Ann N Y Acad Sci | 2020 | https://conductscience.org/library/papers/31588569 | PubMed |
| 6 | 27768847 | Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump. | ACS Infect Dis | 2017 | https://conductscience.org/library/papers/27768847 | PubMed |
| 7 | 28926596 | Bifurcation kinetics of drug uptake by Gram-negative bacteria. | PLoS One | 2017 | https://conductscience.org/library/papers/28926596 | PubMed |
| 8 | 29756762 | Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa. | ACS Infect Dis | 2018 | https://conductscience.org/library/papers/29756762 | PubMed |
| 9 | 26976576 | Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. | Proc Natl Acad Sci U S A | 2016 | https://conductscience.org/library/papers/26976576 | PubMed |
| 10 | 22451937 | Transport of drugs by the multidrug transporter AcrB involves an access and a deep binding pocket that are separated by a switch-loop. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22451937 | PubMed |
| 11 | 28224989 | Mechanisms of envelope permeability and antibiotic influx and efflux in Gram-negative bacteria. | Nat Microbiol | 2017 | https://conductscience.org/library/papers/28224989 | PubMed |
| 12 | 28157293 | Whole-Cell-Based Assay To Evaluate Structure Permeation Relationships for Carbapenem Passage through the Pseudomonas aeruginosa Porin OprD. | ACS Infect Dis | 2017 | https://conductscience.org/library/papers/28157293 | PubMed |
| 13 | 29661860 | Substrate Specificities and Efflux Efficiencies of RND Efflux Pumps of Acinetobacter baumannii. | J Bacteriol | 2018 | https://conductscience.org/library/papers/29661860 | PubMed |
| 14 | 33596653 | The Whole Is Bigger than the Sum of Its Parts: Drug Transport in the Context of Two Membranes with Active Efflux. | Chem Rev | 2021 | https://conductscience.org/library/papers/33596653 | PubMed |
| 15 | 29446459 | The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics. | Ann N Y Acad Sci | 2019 | https://conductscience.org/library/papers/29446459 | PubMed |
| 16 | 26478537 | Quantification of Fluoroquinolone Uptake through the Outer Membrane Channel OmpF of Escherichia coli. | J Am Chem Soc | 2015 | https://conductscience.org/library/papers/26478537 | PubMed |
| 17 | 29317622 | Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition. | Nat Commun | 2018 | https://conductscience.org/library/papers/29317622 | PubMed |
| 18 | 29089426 | Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria. | mBio | 2017 | https://conductscience.org/library/papers/29089426 | PubMed |
| 19 | 25910245 | Toward the rational design of carbapenem uptake in Pseudomonas aeruginosa. | Chem Biol | 2015 | https://conductscience.org/library/papers/25910245 | PubMed |
| 20 | 8363364 | Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/8363364 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40867973 | Efflux-Mediated Resistance in Enterobacteriaceae: Recent Advances and Ongoing Challenges to Inhibit Bacterial Efflux Pumps. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40867973 | PubMed |
| 39085542 | Sophisticated natural products as antibiotics. | Nature | 2024 | https://conductscience.org/library/papers/39085542 | PubMed |
| 37707450 | Eugenol works synergistically with colistin against colistin-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae isolates by enhancing membrane permeability. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/37707450 | PubMed |
| 37371580 | Efflux Pump-Binding 4(3-Aminocyclobutyl)Pyrimidin-2-Amines Are Colloidal Aggregators. | Biomolecules | 2023 | https://conductscience.org/library/papers/37371580 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36070489
GET https://conductscience.org/api/papers/v1/36070489/references?page=2